Loading...
EKF Diagnostics Holdings plc
EKDHF•PNK
Healthcare
Medical - Devices
$0.35
$0.00(0.00%)
EKF Diagnostics Holdings plc (EKDHF) Financial Performance & Income Statement Overview
Review EKF Diagnostics Holdings plc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-4.59%
↓ 4.59%
Operating Income Growth
210.38%
↑ 210.38%
Net Income Growth
165.39%
↑ 165.39%
Operating Cash Flow Growth
116.38%
↑ 116.38%
Operating Margin
12.58%
↑ 12.58%
Gross Margin
48.60%
↑ 48.60%
Net Profit Margin
12.41%
↑ 12.41%
ROE
8.83%
↑ 8.83%
ROIC
8.43%
↑ 8.43%
EKF Diagnostics Holdings plc (EKDHF) Income Statement & Financial Overview
Review EKF Diagnostics Holdings plc's (EKDHF) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
---|---|---|---|---|
Revenue | $24.98M | $25.21M | $16.41M | $15.70M |
Cost of Revenue | $12.65M | $13.15M | $8.49M | $8.13M |
Gross Profit | $12.33M | $12.06M | $7.92M | $7.58M |
Gross Profit Ratio | $0.49 | $0.48 | $0.48 | $0.48 |
R&D Expenses | $0.00 | $0.00 | $1.44M | $1.38M |
SG&A Expenses | $8.92M | $9.16M | $4.82M | $4.61M |
Operating Expenses | $8.92M | $9.16M | $6.55M | $6.27M |
Total Costs & Expenses | -$21.57M | $22.31M | $15.04M | $14.39M |
Interest Income | $76000.00 | $98000.00 | $84018.00 | $5490.00 |
Interest Expense | $60000.00 | $111000.00 | $72561.00 | $0.00 |
Depreciation & Amortization | $2.34M | $2.38M | $1.35M | $1.30M |
EBITDA | $5.61M | $5.55M | $2.99M | $2.86M |
EBITDA Ratio | $0.22 | $0.22 | $0.18 | $0.18 |
Operating Income | $3.42M | $2.90M | $1.63M | $1.56M |
Operating Income Ratio | $0.14 | $0.12 | $0.10 | $0.10 |
Other Income/Expenses (Net) | -$210000.00 | $155000.00 | $1.11M | -$248274.00 |
Income Before Tax | $3.21M | $3.06M | $1.37M | $1.32M |
Income Before Tax Ratio | $0.13 | $0.12 | $0.08 | $0.08 |
Income Tax Expense | -$1.15M | $837000.00 | $474229.00 | $453846.00 |
Net Income | $4.18M | $2.07M | $1.73M | $1.65M |
Net Income Ratio | $0.17 | $0.08 | $0.11 | $0.11 |
EPS | $0.009 | $0.005 | $0.004 | $0.004 |
Diluted EPS | $0.009 | $0.005 | $0.004 | $0.004 |
Weighted Avg Shares Outstanding | $453.73M | $453.73M | $453.78M | $453.78M |
Weighted Avg Shares Outstanding (Diluted) | $453.73M | $453.73M | $453.72M | $453.72M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan